Drug for treating irritable bowel syndrome by cooperating with gastric motivity therapeutic instrument

Abstract

The invention provides a drug for treating an irritable bowel syndrome by cooperating with a gastric motivity therapeutic instrument. The drug is prepared from 3 parts of litchi seeds, 5 parts of dried hyacinth beans, 2.5 parts of dried ginger, 8 parts of glycerin, 2 parts of fumed silica and 1.5 parts of micro carbonized corn flour. A preparation method of the drug comprises the steps that the litchi seeds are crushed and then mixed with the dried hyacinth beans and the dried ginger, and then all the materials are ground into powder A; the micro carbonized corn flour is mixed with glycerin and fumed silica, grinding is conducted till the granule size distribution of the micro carbonized corn flour ranges from 60 micrometers to120 micrometers, and a material B is obtained; the powder A is added to the material B, the materials are stirred and mixed to be uniform and subjected to cold storage for 10 min in an environment of -15 DEG C, the materials are taken out, the temperature is naturally raised to 5 DEG C or above, and the drug is obtained. According to the drug for treating the irritable bowel syndrome by cooperating with the gastric motivity therapeutic instrument, the drug and the gastric motivity therapeutic instrument are mutually synergistic, under the current irritation of the gastric motivity therapeutic instrument, drug absorption is rapid, the utilization ratio of the drug is high, and the drug efficacy is obvious; under the adjuvant therapy of the drug, the therapeutic effect of the gastric motivity therapeutic instrument on the irritable bowel syndrome is more obvious, the effect is rapid to achieve, and the treatment cycle is shortened.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a medicine for treating irritable bowel syndrome combined with a gastric motility therapeutic apparatus. Background technique [0002] A specific area of ​​the gastrointestinal tract can drive the contraction of gastrointestinal smooth muscle and control the basic bioelectrical rhythm of the gastrointestinal tract. In medicine, this specific area is called a gastrointestinal pacemaker (Pacemaker). [0003] The working principle of the gastric motility therapy device is based on the fact that the electrical activity of the gastrointestinal pacemaker can be driven by the external current stimulation, which promotes the disordered gastrointestinal electrical activity to produce a follow-up effect to restore the normal rhythm, thereby achieving the treatment of various functional gastrointestinal diseases the goal of. [0004] However, because people's constitutions are different and their c...

AI Technical Summary

Problems solved by technology

[0004] However, due to the different physiques and different conditions of people, sometimes, the therapeutic effect of simply using gastric motility therapy equipment is not significant.